Article
Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
Oncology reports - 1 Nov 2015
Ratajska Magdalena, Matusiak Magdalena, Kuzniacka Alina, Wasag Bartosz, Brozek Izabela, Biernat Wojciech, Koczkowska Magdalena, Debniak Jaroslaw, Sniadecki Marcin, Kozlowski Piotr, Klonowska Katarzyna, Pilyugin Maxim, Wydra Dariusz, Laurent Geoff, Limon Janusz, Irminger-Finger Irmgard
Abstract excerpt
BARD1 is the main binding partner of BRCA1 and is required for its stability and tumor-suppressor functions. In breast cancer and other epithelial cell carcinomas, alternatively spliced isoforms of BARD1 are highly upregulated and correlated with poor outcome. Recent data indicate that germline mutations of BARD1 may predispose to breast and/or ovarian cancer. To evaluate the role of BARD1 germline mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
